Full text loading...
Ellagic acid, a BCS Class IV drug, suffers from poor solubility and permeability, limiting its therapeutic potential despite its wide pharmacological activities. This study aimed to develop a coconut oil-based Ellagic acid Nanoemulsion (CoEaNe) and evaluate its wound-healing efficacy.
CoEaNe was prepared using a modified ultrasonication process. Drug loading and entrapment efficiency were assessed via UV spectroscopy. Particle size and polydispersity index were measured with a zeta sizer, while particle morphology was examined using Field Emission Scanning Electron Microscopy (FESEM). In-vivo wound-healing activity was evaluated in the Albino Wistar rat model. Drug release kinetics were analyzed using various mathematical models.
The nanoemulsion exhibited a Z-average of 137.9 nm with spherical morphology and demonstrated zero-order release kinetics. FESEM confirmed uniform spherical particles. In vivo, CoEaNe significantly enhanced wound healing, achieving complete closure of burn wounds compared to controls.
The research findings highlight the potential of CoEaNe as a promising drug delivery system for poorly soluble BCS Class IV drugs. The enhanced wound-healing effect may be attributed to the optimized particle size, sustained drug release, and improved entrapment efficiency.
Coconut oil-based Ellagic acid Nanoemulsion (CoEaNe) has optimal and favorable physicochemical properties, efficient drug loading, and significant wound-healing efficacy in-vivo, suggesting its applicability as a novel carrier system for enhancing therapeutic outcomes of poorly soluble drugs.